CYBERDYNE Inc.

Equities

7779

JP3311530004

Healthcare Facilities & Services

Delayed Japan Exchange Other stock markets 02:44:19 10/05/2024 BST			5-day change	1st Jan Change
205 ^JPY	-0.97%		+1.99%	-8.48%

04-30	Cyberdyne May Book 18 Million Yen Provision for Doubtful Accounts in Fiscal 2024 Due to Non-collectable Claims	MT
02-15	CYBERDYNE Inc. Signs Business Consignment Agreement with New Energy and Industrial Technology Development Organization	CI

LPixel Inc. announced that it has received $30 million in funding from Olympus Corporation, CYBERDYNE Inc., Fujifilm Corporation, SBI Investment Co., Ltd., JAFCO Co., Ltd., TechMatrix Corporation and another investor

October 28, 2018

LPixel Inc. announced that it has received $30,000,000 in a round of funding on October 29, 2018. The transaction includes participation from new investors, Olympus Corporation (TSE:7733), CYBERDYNE Inc. (TSE:7779), Fujifilm Corporation, SBI Investment Co., Ltd., JAFCO Co., Ltd. (TSE:8595), TechMatrix Corporation (TSE:3762), Cybernic Excellence Japan Fund 1 Investment Limited Partnership, a fund managed by CEJ Capital, Inc.

Stocks mentioned in the article

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
OLYMPUS CORPORATION	2,296 JPY	+0.61%	+1.73%	16.91B
TECHMATRIX CORPORATION	1,806 JPY	+7.18%	+10.55%	437M
JAFCO GROUP CO., LTD.	1,775 JPY	-0.42%	+0.31%	621M

Latest news about CYBERDYNE Inc.

Cyberdyne May Book 18 Million Yen Provision for Doubtful Accounts in Fiscal 2024 Due to Non-collectable Claims	04-30	MT
CYBERDYNE Inc. Signs Business Consignment Agreement with New Energy and Industrial Technology Development Organization	02-15	CI
Cyberdyne Foresees Potential Bad Debt Loss Amid OCT's Bankruptcy Proceedings	12-29	MT
Cyberdyne to Sign a Consignment Agreement with NEDO; Expects 332 Million Yen in Other Income for Fiscal 2023	12-06	MT
Cyeberdyne Appoints Shinji Honda as New Executive Director and COO	12-05	MT
CYBERDYNE Inc. Appoints Shinji Honda as New Executive Director and Chief Operating Officer, Effective December 18, 2023	12-03	CI
Cyberdyne Books 660 million Yen in Impairment Loss in Fiscal Q2	11-15	MT
Cyberdyne Secures Grant for Development of Robotic Care Device Overseas	09/08/23	MT
Certain Common Stock of Cyfuse Biomedical K.K. are subject to a Lock-Up Agreement Ending on 1-JUN-2023.	31/05/23	CI
CYBERDYNE Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	15/05/23	CI
CYBERDYNE Inc. completed the acquisition of 8% stake in LeyLine GmbH from Midori Moriwaki.	30/03/23	CI
Cyberdyne to Take Controlling Stake in German Racing Team Operator	30/03/23	MT
CYBERDYNE Inc. signed an agreement to acquire 8% stake in LeyLine GmbH from Midori Moriwaki.	28/03/23	CI
Certain Common Stock of Cyfuse Biomedical K.K. are subject to a Lock-Up Agreement Ending on 28-FEB-2023.	27/02/23	CI
Cyberdyne Repurchases 1.2 Billion Yen Worth of Stock; Shares Gain 4%	21/02/23	MT
Tranche Update on CYBERDYNE Inc.'s Equity Buyback Plan announced on February 20, 2023.	21/02/23	CI
CYBERDYNE Inc.'s Equity Buyback announced on February 20, 2023, has closed with 4,000,000 shares, representing 1.86% for ¥1,188 million.	20/02/23	CI
CYBERDYNE Inc. announces an Equity Buyback for 4,000,000 shares, representing 2.91% for ¥1,188 million.	20/02/23	CI
CYBERDYNE Inc. authorizes a Buyback Plan.	19/02/23	CI
Cyberdyne Inc. Announces Yuzo Toda Passed Away on December 27, 2022, and Retired from the Position of Director on the Same Day	06/01/23	CI
Cyfuse Biomedical K.K. has completed an IPO in the amount of Ã‘2.477466 billion.	01/12/22	CI
Cyfuse Biomedical K.K. has filed an IPO.	27/10/22	CI
Hirosaki Lifescience Innovation, Inc. announced that it has received funding from CYBERDYNE Inc.	16/08/22	CI
Xenoma, Inc. announced that it has received funding from CYBERDYNE Inc.	09/08/22	CI
Metcela Inc. announced that it has received ¥1.87 billion in funding from CYBERDYNE Inc., CEJ Capital Co., Ltd., Japan Lifeline Co., Ltd., Sony Ventures Corporation, Reazon Holdings, Inc.	27/06/22	CI

Chart CYBERDYNE Inc.

Duration

Period

More charts

Company Profile

Cyberdyne Inc is engaged in the research, development, manufacture, sale, and maintenance management related to Cybernics technology. The Company mainly uses human and the Internet of Things (IoH/IoT), robots, and artificial intelligence (AI) Cybernics technology to develop Cybernic systems. It develops the Cybernics treatment service business and the training service business that utilize Cybernics technology. The Company develops in various fields centered on HAL. HAL is a robot treatment device for the purpose of improving and regenerating the physical function of patients, a welfare device and life support device for the purpose of supporting independence, and a work support equipment. It can be used for various purposes by being worn and used by people. The Company is also involved in the productization of AI-equipped transport robots; cleaning robots; Cyin, which is used for communication with people with disabilities, and electrocardiography devices.

Sector

Healthcare Facilities & Services

Calendar

14/05/2024 - Q4 2023 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for CYBERDYNE Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

207 JPY

Average target price

320 JPY

Spread / Average Target

+54.59%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
CYBERDYNE INC.	-8.48%	280M
HCA HEALTHCARE, INC.	+18.92%	81.04B
CVS HEALTH CORPORATION	-29.48%	68.93B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+9.65%	29.59B
FRESENIUS SE & CO. KGAA	-0.14%	17.24B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-9.30%	16.99B
QUEST DIAGNOSTICS INCORPORATED	+0.20%	15.12B
REDE D'OR SÃO LUIZ S.A.	+5.25%	13.09B
TENET HEALTHCARE CORPORATION	+68.96%	12B
EUROFINS SCIENTIFIC SE	-2.88%	11.94B

Other Healthcare Facilities & Services